Print Page
3004:
Prescribing IgG for Immunodeficiency
Immunodeficiency
Sunday, March 4, 2018: 7:00 AM-8:00 AM
Hyatt, Convention Level, Celebration 3
1.00 CME/CE
Seminar
Primary Discussion Leaders:
Mark Ballow, MD FAAAAI
Elena E. Perez, MD PhD FAAAAI
David M Edgar, FRCP FRCPath

Learning Objectives:
  1. Discuss how to counsel patients on the risks and benefits of IgG therapy as well as decisions regarding route and frequency of administration
  2. Discuss how to make patient specific selections, where appropriate, of immunoglobulin products and correctly write orders for IgG therapy
  3. Describe the relative importance of the characteristics of immunoglobulin products
Handouts
  • AAAAI printed handout 3004.pdf (142.5 kB)
    • See more of: Session
    << Previous Session | Next Session >>